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ABSTRAK 
Penyakit Osteoporosis telah pun biasa diperkatakan dan ia telah 
menyebabkan kepada insiden kepatahan tulang sebanyak 8.9 juta kes setiap tahun. 
Kebanyakan kajian kepatahan tulang femur atas mengatakan osteoporosis adalah 
penyebab utama walaupun tiada satu kajian pun mengatakan nilai kepadatan tulang 
yang dapat mengelakkan daripada kepatahan sedemikian berlaku. 
 
Objektif 
Kajian ini adalah Analisis Keratan rentas untuk menentukan nilai kepadatan 
tulang pesakit-pesakit berumur yang dimasukkan ke hospital disebabkan kepatahan 
tulang femur atas sepertimana yang ditentukan oleh mesin Imbasan DXA dan juga 
menentukan bio-demography pesakit-pesakit tersebut. 
 
Metodologi 
Nilai kepadatan tulang seramai 15 orang pesakit yang mengalami kepatahan 
tulang femur atas ditentukan menggunakan mesin Imbasan DXA. Nilai skor T akan 
dikaji secara lebih terperinci untuk mengetahui perkaitan dengan osteoporosis 
dikalangan pesakit di atas.  
 
Keputusan 
Nilai purata umur di kalangan pesakit adalah 70 tahun, dan 80% daripada 
mereka adalah berbangsa melayu.60% daripada mereka tidak mengambil pemakanan 
berasaskan susu, dan 80% datang dari kalangan berpendapatan rendah. Hanya 33% 
adalah perokok. Kepadatan tulang neck hip di kalangan pesakit menunjukkan bacaan 
median terendah -1.70 dan julat interquartil adalah 1.10. Seterusnya, bacaan 
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kepadatan tulang diikuti oleh hip keseluruhan dan spine masing-masing dengan 
bacaan median -1.60 dan -1.40. Sebahagian besar pesakit yang terlibat dalam kajian 
ini mempunyai kepadatan mineral tulang kumpulan osteopenic. Peratusan osteopenic 
tertinggi adalah  neck hip dengan bacaan 66.7%. Diikuti dengan hip keseluruhan dan 
spine masing-masing dengan nilai bacaan 60.0% dan 33.3%. Peratusan pasakit di 
bawah kumpulan osteoporosis masing-masing untuk hip keseluruhan, spine dan neck 
hip adalah 6.7%, 33.3% and 20%. 5 (33.3%) pesakit mempunyai nilai BMD hip 
kesuluruhan sebagai normal, 5 (33.3%) pesakit untuk spine dan 2 (20%) pesakit 
untuk neck hip. Dari keseluruhan 15 pesakit, hanya seorang pesakit mempunyai nilai 
ketiga-tiga tempat kepadatan tulang sebagai osteoporosis. Analisis ketepatan Fisher 
menunjukkan tiada sigifikan perkaitan antara bio-demografik dan nilai kepadatan 
tulang di kesemua kawasan yang telah di nilai.    
 
Kesimpulan 
Kajian menunjukkan tiada sigifikan perkaitan antara bio-demografik dan nilai 
kepadatan tulang di kesemua kawasan yang telah di nilai. Sebahagian besar pesakit 
yang terlibat dalam kajian ini mempunyai kepadatan mineral tulang kumpulan 
osteopenic. Peratusan osteopenic tertinggi adalah  neck hip dengan bacaan 66.7%,  
diikuti dengan hip keseluruhan dan spine masing-masing dengan nilai bacaan 60.0% 
dan 33.3%. 
Kata Kunci: Nilai kepadatan tulang, Imbasan DXA, osteoporosis, kepatahan tulang 
femur atas 
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ABSTRACT 
Osteoporosis has been recognized as an established and well-defined disease 
that affects more than 8.9 million fractures annually worldwide. Most studies of 
fracture involving the proximal femur claim that generalized osteoporosis is the 
major etiological factor, although none has established a densitometric fracture 
threshold above which such fractures would not occur.  
 
Objectives 
This is a cross sectional analytical study with aims to identify the bone 
mineral density of elderly patients admitted for fracture proximal femur in an 
institution as assessed by Dual Energy X-Ray Absoptiometry (DXA) scan as well as 
to determine the biodemographics of the said profiles. 
 
Methodology 
Bone mineral density of 15 patients admitted for proximal femur fractures 
were evaluated using DXA scan.The T-score was further evaluated to see the 
significance of osteoporosis in these sujects. 
  
Results 
The mean age of the subject was 70 years old, and 80% were malays. 60% of 
them were non-milk consumer, and 80% were categorized under low socioeconomic 
group. Only 33% were a smoker. Bone density of neck of hip among the patients had 
the lowest median with -1.70 and interquartile range of 1.10. Then, it was followed 
by bone density for total hip and spine with median value of -1.60 and -1.40 
respectively. Majority of the patients who involved in this study had their bone 
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mineral density value as osteopenia. The highest osteopenia percentage was for the 
neck of hip, 66.7 %. Then it was followed by total hip and spine, 60% and 33.3 % 
respectively. The percentage of patients with osteoporotic group of BMD for total 
hip, spine and neck of hip were 6.7%, 33.3% and 20% respectively. 5 (33.3%) 
patients had their BMD total hip as normal, 5 (33.3%) patients for spine and 2 (20%) 
patient for neck of hip. Out of 15 subjects, only 1 who had all three BMD value of 
total hip, spine and neck of hip as osteoporosis. Fisher’s Exact test analysis found 
that there were no significant association between studied bio-demographic and bone 
mineral density at all measured sites. 
 
Conclusion 
This study found that there were no significant association between studied 
bio-demographic and bone mineral density at all measured sites. Majority of the 
patients who involved in this study had their bone mineral density value as 
osteopenia. The highest osteopenia percentage was for the neck of hip, 66.7 %, 
followed by total hip and spine, 60 and 33.3 % respectively. 
Keywords: Bone mineral density, DXA scan, osteoporosis, proximal femur fracture
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1. INTRODUCTION 
Osteoporosis is a worldwide problem with significant economic and social 
impact. Osteoporosis related fracture has been recognized as a major health problem, 
particularly in elderly. Hip fractures are associated with high morbidity and mortality 
rate up to 20% in the first year. Majority of those who survive are disabled and only 
25% will resume normal activities. In 1997, the incidence of hip fracture in Malaysia 
among individuals above 50 years old was 90 per 100 000 cases. The direct 
hospitalization cost for hip fracture in 1997 in Malaysia was estimated at RM 22 
million. This was a gross underestimate of the total economic burden, as it does not 
take into account the costs involved in rehabilitation and long term nursing care of 
the involved patients (Clayer and Bauze 1989). Affected patients may develop 
associated complications such as pressure ulcers, pneumonia, urinary tract 
complications and severe depression. Half of those who were ambulatory before the 
fractures are unable to walk without assistance subsequently and one-quarter require 
long-term domiciliary care (Phillips et al 1988). 
Because bone loss occurs insidiously and is initially asymptomatic, 
osteoporosis is often only diagnosed after the first clinical fracture has occurred 
(Vestergaard et al 2005). Consequently, the aim of therapy is usually prevention of 
further fractures. Early assessment of an individual’s risk of osteoporosis is therefore 
important to prevent the first fracture. Providing an easily available and cost effective 
screening tool for initiation of treatment and treatment monitoring are important in 
preventing the devastating outcome of osteoporosis. 
National and international guidelines have been implemented to address the 
challenge of screening for osteoporosis in an evidence-based and cost-effective 
manner. Several risk factors, such as age, low body-mass index, previous fragility 
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fractures, a family history of fractures, the use of glucocorticoids, and active cigarette 
smoking have to be taken into account (Kanis 2002). The measurement of BMD by 
DXA is a valid method to diagnose osteoporosis and to predict the risk of fracture 
(Cummings et al 2002). New decision-making methods, such as the fracture-risk 
assessment tool (FRAX), have integrated clinical risk factors with DXA-based BMD 
to predict an individual’s 10-year risk of sustaining a hip fracture as well as the 10-
year probability of having a major osteoporotic fracture, defined as clinical spine, 
forearm, hip, or shoulder fracture (Unnanuntana et al 2010). 
In the current practice, when an elderly patient presents with a fracture 
following trivial trauma, osteoporosis is a presumptive diagnosis after excluding 
secondary causes of bone loss. A baseline bone mineral density measurement is 
advised for these patients. In the absence of fracture, the gold standard of diagnosis 
of primary osteoporosis in asymptomatic patients remains the measurement of bone 
mineral density using DXA (Clayer and Bauze 1989). The BMD measurement gives 
an accurate reflection of bone mass. The risk of fracture is increased 2 folds for each 
SD reduction in BMD. 
Most studies of fracture of the proximal femur claim that generalized 
osteoporosis is the major etiological factor, although none has established a 
densitometric fracture threshold above which such fractures would not occur. Dual 
energy x-ray absorptiometry techniques have been validated for the quantitative 
assessment of bone mass at two skeletal sites particularly at risk of osteoporotic 
fracture, i.e., lumbar spine and proximal femur. These measurements assess areal 
bone mineral density (BMI), which integrates the size of the bone and its thickness, 
as well as the true volumetric density. Area of density provides useful information 
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relative to fracture risk, since there is an inverse relationship between incidence of 
osteoporotic fractures and area of BMD. 
Several studies have concluded that incidences of osteoporosis and 
osteoporosis-related fractures (hip, spine, distal radius, and humerus) vary across the 
world. It is reasonable to hypothesize that Malaysia might be a low-risk country for 
osteoporosis because it is an Asian country. However, there is a lack of studies and 
insufficient information to confirm this theory. In addition, comparison rates with 
other countries have not yet been established (Lee et al 2013). 
Furthermore, the role of osteoporosis in the occurrence of hip fractures 
remains controversial. Some investigators have found that patients with hip fractures 
have substantially less bone at various sites than subjects of similar ages who have 
not had fractures. Other investigators have found no significant difference in bone 
mass between these two groups (Bohr and schaadt 1963). 
Preventing osteoporosis would appear to be a logical way of preventing 
proximal femur fracture, but before embarking on such a program it would be 
essential to know the proportion of patients who would not have sustained a fracture 
had their bone mass been normal in our population. We therefore report a 12 month 
cross sectional study conducted in the Hospital Raja Perempuan Zainab II in 
Kelantan, aimed at obtaining an estimate of the proportion of proximal femoral 
fractures that are not related to generalize osteoporosis. Hospital Raja Perempuan 
Zainab II is one of the referral centers in managing osteoporosis and fracture related 
osteoporosis in the state of Kelantan. 
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1.1 Rationale of the study 
1. Most of the previous studies were done in other countries. There was no 
previous study investigating the bone mineral density in fracture proximal 
femur particularly in elderly people in our population. Therefore the aim was 
to conduct a local study,  specific to population in Kelantan. 
2. The ever increasing incidence of fracture of the proximal femur is generating 
escalating costs. By knowing the true etiology of the fracture behind, we may 
provide the true preventive measures, hence managing the cost appropriately. 
 
1.2 Research Questions 
1. Do the elderly patient with fracture at the proximal femur, have bones which 
are really osteoporotic by WHO definition ? 
2. Is the quantitative bone mineral density (T-score) of those with fracture 
proximal femur worse or similar with the WHO classification? 
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2. LITERATURE REVIEW 
2.1 Introduction 
Osteoporosis, characterized by generalized reduction in bone mass and strength 
that results in fragility fracture, has existed throughout human history. It was first 
noted in the 19th century by an English Surgeon, Sir Astley Cooper. He described 
osteoporosis as "the lightness and softness of bone that is acquired in the more 
advanced stages of life" and that "this state of bone favors much the production of 
fracture" (Raisz 2005 ). 
In 1940, Fuller Albright (American physician and endocrinologist) described 
postmenopausal osteoporosis and suggest its correlation with estrogen deficiency. 
Subsequently, the concept of two forms of osteoporosis, postmenopausal with 
correlation to estrogen deficiency and senile type which is related to calcium 
deficiency and aging of the skeleton was proposed. This is later replaced by the 
current concept that osteoporosis is resulting from multiple pathogenetic 
mechanisms leading to loss of bone mass and microarchitectural deterioration of 
skeletal structure (Raisz 2005). 
 
2.2 Definition osteoporosis 
According to NIH Consensus Development Panel on Osteoporosis 
Prevention, Diagnosis, and Therapy (JAMA 2001), osteoporosis is defined as a 
systemic skeletal disorder characterized by compromised bone strength predisposing 
a person to an increased risk of fracture. Bone strength is determined by both bone 
density and bone quality. Bone density (g/cm2 or g/cm3) is determined by peak bone 
mass and amount of bone loss. 
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𝐵𝑀𝐷 = 𝐵𝑜𝑛𝑒 𝐷𝑒𝑛𝑠𝑖𝑡𝑦 ( 𝑔𝑟𝑎𝑚𝑠)
𝐴𝑟𝑒𝑎 ( 𝑐𝑚2)  
 
Bone quality refers to architecture, turnover, damage accumulation such as 
microfracture, and mineralization. A fracture occurs when a force that causes failure 
is applied to the osteoporotic bone. Thus, osteoporosis is a significant risk factor for 
fracture. 
In women, the diagnosis of osteoporosis is made on the basis of bone mineral 
density (Table 2.1) as published in the WHO technical report series 843 
(Organization 1994). The peak bone mineral density is achieved during the third 
decade of life and decline afterwards with advancing age (Figure 2.1). In women, 
this decline accelerates with menopause. The BMD value of -2.5 below the mean for 
the young adult (T score) identifies up to 95% of women at highest risk of fracture 
(Ryan 1997). 
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Table 2.1: The World Health Organization (WHO) working group classification of 
osteoporosis1 
Type Bone Mineral Densiy (BMD) value 
Normal BMD within 1 SD of young adult reference range  (T score > -1) 
Osteopenia 
BMD more than 1 SD but less than 2.5 SD below the 
young adult mean  
(T score between -1 and -2.5) 
Osteoporosis 
BMD value of 2.5 SD or more below the young adult 
mean  
(T score <-2.5) 
Severe/ Established 
Osteoporosis 
BMD value of 2.5 SD or more below the young adult 
mean with the presence of 1 or more fragility fractures 
* T score comparison with young adult mean 
 
 
 
Figure 2.1: Bone Loss during adult life (Riggs and Melton III 1986) 
 
2.3 Classification and clinical presentation of osteoporosis 
Osteoporosis is often divided into primary and secondary osteoporosis 
syndrome (Riggs et al 2001). The basis of the classification is on whether or not the 
patient has a recognizable disease or due to other causes such as consumption of 
drugs resulting in bone loss (Table 2.2). 
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Table 2.2: Secondary Osteoporosis2 
Causes Examples 
Endocrine 
• Cushing's syndrome 
• Hypogonadism 
• Thyrotoxicosis 
• Hyperparathyroidism 
Drugs 
• Glucocorticoids 
• Heparin 
• Anticonvulsants (phenytoin) 
• Immunosuppresants 
Chronic 
diseases 
• Renal impairment 
• Liver cirrhosis 
• Malabsorption/ post-gastrectomy 
• Chronic inflammatory polyarthropathies (e.g. rheumatoid arthritis) 
Others 
• Nutritional 
• Multiple myeloma and malignancy 
• Osteogenesis imperfecta 
 
Three subgroups of osteoporosis fall under primary osteoporosis: 
1. Type I osteoporosis (Postmenopausal) 
2. Type 2 osteoporosis (Age related/Senile) 
3. Idiopathic osteoporosis. 
 
It is generally accepted that idiopathic osteoporosis that occur in young adults 
and involving both genders should be considered as a separate entity (Riggs et al 
2001). The term involutional osteoporosis was previously used for type I and type 2 
osteoporosis because both of the conditions occur in both genders and are strongly 
related to age. The sub classification of involutional osteoporosis into these two 
types was proposed by Riggs and Melton in 1986 and subsequently in other 
publications. Type 1 and 2 osteoporosis differed with respect to changes in regional 
bone mineral density, fracture pattern, associated hormonal changes and underlying 
pathophysiology (Riggs et al 2001). 
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Type 1 osteoporosis usually affects women within 15 to 20 years after 
menopause. The typical presentations are fractures occurring at sites that contain 
larger amounts of cancellous bone as in the vertebral body, distal end of radius and 
ankle. The vertebral fractures are typically of compression or collapse type and 
associated with reduction of more than 25% of vertebral height. These types of 
fractures are commonly painful and take longer time to subside (Riggs BL et al 
2001.) 
Type 2 osteoporosis affects both genders but it is twice as common in women as 
in men. It is a predominant form of osteoporosis in elderly over the age of 70 years 
old. The fracture pattern in this group is one that typically occurs at sites that 
contain both cancellous and cortical bone. The most common sites are the hip 
region and proximal humerus. In spine, typical features are of gradual and 
progressive deformity leading to dorsal kyphosis (the "dowager's hump"). These 
fractures are usually painless or associated with minimal pain. The radiographs 
show less than 25% vertebral height reduction with anterior wedge deformities. 
They mainly involved the mid thoracic area and occurred in multiple adjacent 
vertebrae. (Riggs et al 2001). 
 Table 2.3: Characteristics of osteoporosis type 1 and type 2 (Riggs et al 2001)3  
Characteristics Type 1 Type 2 
Age (years)  51-75 >70 
Sex ratio (F:M) 6:01 2:01 
Type of bone loss Trabecular Trabecular and cortical 
Rate of bone loss Accelerated Not accelerated 
Major  
fracture sites 
Vertebrae (crush) 
and distal radius 
Vertebrae (multiple wedge) and 
hip 
Parathyroid function Decreased Increased 
Estrogen effects Mainly skeletal Mainly extraskeletal 
Main causes Menopause plus 
individual 
predisposing 
 
Factors related to aging 
including late effects of estrogen 
deficiency 
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The manifestations of osteoporosis type 1 and type 2 are closely related to 
underlying patterns of age related bone loss. Based on cross-sectional and logitudinal 
bone densitometric studies (Riggs et al 2001), there are two phases of age related 
bone loss identified. The slow age related or involutional loss and the accelerated 
phase that occur only in postmenopausal women due to the reduction of estrogen 
level. 
The slow phase begins at about 35 - 40 years old and continues throughout 
life. The rate of loss is less than 0.5% per year and similar in both gender and results 
in loss of similar amount of cortical and cancellous bone. It includes for maximum 
bone loss of 20% in total. It is due to subtle uncoupling of rate of bone formation and 
resorption. The accelerated phase occurs only in postmenopausal women. It 
superimposes the slow loss and results in loss of more cancellous bone.  
The most affected sites are the spine and distal end of radius. The accelerated 
lost last about 10 years with the rate of approximately 1 % to 2% per year and 
maximum total loss of 10% throughout. The main lost usually occur during the first 
three years of menopause. 
 
Figure 2.2: Changes in bone mass in aging men and women showing pattern of bone 
loss. (I) Peak bone mass, (II) rapid phase of bone loss in women around menopause, 
(III) is age related bone loss, similar in men and women (Riggs et al 2001). 
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 Of all osteoporotic related fractures, fractures around the hips are the most 
disabling. It is associated with higher morbidity and mortality of up to 20% within 
the first year of injury. Majorities are disabled and only 25% resume premorbid 
activities (Jensen and Bagger 1982). It imposes a considerable financial burden on 
the health services due to related problem of patient's immobilization and cost of 
hospitalization. In the European Union, osteoporosis patients occupied 500,000 
hospital bed-nights per year, and this was expected to double by 2050 worldwide 
(Clayer and Bauze 1989).  
Few studies regarding the incidence of hip fracture have been reported in 
Asian countries. The Asian Osteoporosis Study was the first multicenter study 
documenting and comparing the incidence of hip fracture in four Asian countries 
namely the Hong Kong SAR, Singapore, Malaysia and Thailand (Chiang Mai) in 
1997. In Hong Kong the age-adjusted rates for hip fracture in men and women were 
180 and 459 per 100,000 respectively, 88 and 218 per 100,000 in Thailand, 164 and 
442 per 100,000 in Singapore. In Malaysia, the incidence was 88 and 218 per 
100,000 populations. The study showed moderate variation of incidence hip fracture 
among Asian countries and the rates were highest in urbanized countries (Lau et al 
2001). 
 
2.4 Risk factor for osteoporosis 
Osteoporosis is a silent systemic disease without any obvious symptoms until 
the event of fragility fracture. Since population screening is not cost effective, 
identification of individual at risk will help in case finding (Eddy et al 1998). The 
major factors contributing to increased risk of osteoporosis and osteoporotic fracture 
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in post menopausal women are shown in Table 2.4 (National Osteoporosis 
Foundation 1999). 
L. Koh identified the combination weight and age as the most reliable risk 
factors to predict osteoporosis in post-menopausal Asian women (Koh et al 2001). 
Postmenopausal women were stratified into low, medium and high risk group based 
on their weight and height. Validation studies were performed in four Asian 
countries (Japan, Korea, Singapore and China) followed by design of a simple chart 
known as Osteoporosis Self-Assessment tool for Asians (Figure 2.3). The validation 
studies found that, those who belong in the high risk group are at 61% risk of having 
osteoporosis (Table 2.5). The high risk group patients are recommended for BMD 
measurement, however pharmacologic treatment should be considered in this group 
even if BMD is not available. This chart was used as screening tool to target BMD 
measurement to high risk women and reduced the overall need of BMD 
measurements. 
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Table 2.4: Risk Factors (From National Osteoporosis Foundation 1999: Physician's 
guide to prevention and treatment of Osteoporosis)4 
Type Risk Factor 
Non--modifiable 
• Advancing age 
• Ethnic group 
• Female gender 
• Premature menopause (< 45 years) including surgical 
menopause 
• Slender build 
• Family history of 
• Osteoporosis in first degree relative 
• Personal history of fracture as an adult 
Modifiable 
• Low calcium intake 
• Sedentary lifestyle 
• Smoking cigarette  
• Excessive alcohol intake 
• Excessive caffeine intake 
• Low body weight (<1271b) 
• Estrogen deficiency 
• Impaired vision 
• Recurrent falls 
. 
 
 
Figure 2.3: Osteoporosis Self-assessment Tool for Asia (OSTA) and treatments 
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Table 2.5: Risk stratification5 
Risk Level % with osteoporosis Recommended Approach  
Low 3 BMD measurement probably not 
necessary unless other risk factors are 
 Medium 15 Measure BMD and consider  
pharmacologic treatment if BMD is low 
High 
 
61 BMD measurement if possible. 
Consider pharmacologic treatment even 
if BMD is not available. 
 
2.5 Diagnosis 
A thorough clinical evaluation which includes a detailed history, physical 
examination and appropriate laboratory investigations to rule out secondary causes of 
osteoporosis as mentioned before, are the first key step to diagnose primary 
osteoporosis. Multiple risk factor assessment does not predict bone mass precisely 
(Slemenda et al 1990), but it is the mainstay in decision making to identify patients 
who are at risk and require further investigation. 
Those who presented with fragility fracture following trivial trauma, the 
diagnosis of osteoporosis is presumed after secondary causes are ruled out. BMD 
measurement is recommended in these patients. However, pharmacological treatment 
is still initiated even if BMD is not available. Those without fractures, BMD 
measurement is still the gold standard to diagnose osteoporosis. 
Three aims of investigation are: 
1. To confirm the diagnosis of osteoporosis. 
2. To asses fracture risk. 
3. To exclude secondary causes. 
There is no single specific laboratory investigation available to diagnose 
primary osteoporosis. The role of Full blood count and ESR (Erythrocyte 
Sedimentation Rate) are to assess general condition of the patient and to rule out 'red 
flags' such as infection and malignancy. In other metabolic causes causing bone 
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fragility such as rickets and osteomalacia, serum calcium and phosphate will be show 
abnormality. Alkaline phosphatase is a marker for bone turnover. Elevated level is 
expected in fractures or primary or secondary malignancies of the bone. Renal 
function test is done in those suspected of osteoporosis secondary to chronic or end 
stage renal failure. Other specific laboratory investigation should be performed to 
rule out secondary causes of osteoporosis based on clinical suspicion which include: 
1. Thyroid function test for assessment of hyper or hypothyroidism. 
2. Testosterone level for assessment of hypogonadism in male. 
3. Follicular stimulating hormone and luteinizing hormone level for  
 confirmation of menopause and identifying the cause of estrogen 
deficiency. 
4. Urine Bence Jones and serum electrophoresis performed in suspicion of  
 multiple myeloma. 
  
 Currently, there is no consensus as to the most cost-effective, sensitive 
testing panel for secondary causes of osteoporosis. Testing should be based on the 
individual, with an eye to postmenopausal women with risk factors for secondary 
osteoporosis, and any man or premenopausal woman with history of fragility fracture 
or unexplained bone loss (Kelman and Lane 2005). 
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2.5.1 Specific Investigation   
The role of plain radiograph 
Osteoporosis will only be apparent in plain radiograph only after more than 
30% of bone loss has occurred. Therefore, early diagnosis of osteoporosis is not 
possible using this method. Before the introduction and development BMD 
measurement using DXA scan, several plain radiographic methods have been 
developed for the diagnosis of osteoporosis. These methods involved the study of 
changes of bone morphology in plain radiographs including the spine and the 
proximal femur and the metacarpal bones (Exton-Smith et al 1969). 
In 1960, Barnett and Nordin firstly introduced the use of cortical thickness as a 
predictor of skeletal mineralization. Afterwards, cortical measurements were used 
extensively to estimate osteoporotic changes in the bone. The metacarpal index 
(MCI) is combined cortical thickness of both sides, divided by the outer diameter of 
the measuring site, the mid shaft of the second metacarpal. MCI is reduced with age 
especially in postmenopausal women and correlates with axial bone mass in group 
studies. It can be used for diagnosis of osteoporosis and also for monitoring changes. 
The test is inexpensive and fast. Currently MCI is regaining its popularity among 
tests for bone strength and quantification of bone mass (Nielsen 2001). However, this 
test is not a potent predictor for osteoporotic fracture when studied over a long period 
of time (Kiel et al 2001). 
Concerning on anatomy, the proximal femur is a choice site for the plain 
radiographic study of osteoporosis. Osteoporosis affect different areas of the skeleton 
in different proportions but the spine and the proximal femur are the main sites of the 
main symptoms of the disease such as vertebrae compression fracture and neck of 
femur fractures which make them the most relevant sites for study. However, since 
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the spinal radiographs are difficult to interpret, the proximal femur becomes the area 
of choice. Bone mineral density measurement using DXA scan was later developed 
and accepted as the gold standard method for diagnosis of osteoporosis. It is not a 
suitable for population screening purposes due of constraints of cost and availability. 
Quantitative measurement of bone is not possible with plain X-rays but attempts 
have been made to correlate the bone quality assessed by index measurements using 
plain radiographs with the bone mineral density as measured with DXA scan. 
Singh developed the index measurement of hip region based on changes in 
distribution of the trabecular pattern in the femoral neck in patients with 
osteoporosis (Figure 2.4/Table 2.6). He studied the plain radiographs of non 
fractured hips of 35 patients presented with osteoporotic hip fracture and 
comparing them with the histological changes of the bone taken from the iliac 
crest. They found a highly positive correlation between these two (Singh et al 
1970). The Singh Index was developed based on this finding. Based on the finding 
with increasing degrees of bone loss, six different trabecular patterns can be 
recognized in the upper femur. He suggested that these patterns can be utilized as 
radiographic scale for the diagnosis and grading of osteoporosis. 
Figure 2.4: Normal trabecular pattern of proximal femur (taken from Manmohan 
Singh et al 1970) 
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Figure 2.5: Singh Index (Gaphics are from orthoedicnotes.blogspot.com) 
 
 
 
Table 2.6: Singh index description (from Manmohan Singh et al 1970)6 
Grades Description 
Grade 1 
Principle compressive trabeculae are markedly reduced in number and 
are no longer prominent. 
Grade 2 
Only the principle compressive trabeculae stand out prominently, 
remaining trabeculae have been essentially absorbed 
Grade 3 
There is a break in the continuity of the principal tensile trabeculae 
opposite the greater trochanter, this grade indicates definite 
osteoporosis 
Grade 4 
Principle tensile trabeculae are markedly reduced in number but can 
still be traced from the lateral cortex to the upper part of the femoral 
neck (Borderline) 
Grade 5 
Principle tensile and principle compressive trabeculae is accentuated. 
Ward's triangle appears prominent (early bone loss) 
Grade 6 
All the normal trabecular groups are visible and upper end of the femur 
seems completely occupied by cancellous bone (normal young 
individual) 
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T Masud et al 1995, in the Chingford Study analyzing the screening potential 
of Singh Index found good intra observer reproducibility and significant correlation 
with BMD. Using the criteria of "osteoporosis < Singh grade 4" the sensitivity and 
specificity of Singh Index method in diagnosing low bone mass was 35.1% and 
90.0%, respectively. However, large intra observer variations and low reliability of 
the method were found in many other subsequent studies. This method is no longer 
popular especially for quantification of osteoporosis (Koot et al 1996, Hauschild et al 
2009, Soontrapa et al 2005, Salamat et al 2010). Koot et al 1996 found no significant 
correlation between BMD and Singh Index. Due to its subjective character, its 
predictive value for the mechanical quality of bone in individual patients remains 
uncertain. However, in some cases it can be used to replace the measurement of 
BMD especially in cases of markedly reduced bone mineral density (Krischak et al  
1999). 
 
The role of BMD measurement 
Judging bone density by visual observation and interpretation of a radiograph 
can be imprecise because technical considerations, such as patient size, exposure, 
and processing factors, influence how dense the bones appear. Bone densitometry, by 
contrast, calculates BMD in numerical units and thus provides a more accurate 
representation of bone mineral losses (Adams et al 2008). 
Bone mineral density measurements have an important role in the evaluation 
of patients at risk of osteoporosis, diagnosis and in the appropriate use of anti 
fracture treatment. The WHO committee on osteoporosis defined osteoporosis based 
on the bone density. Based on the standard total BMD of the hip, normal bone is 
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defined as BMD measurement greater than 833mg/cm2, osteopenia is when BMD 
between 833 and 648mg/cm2 and osteoporosis when BMD is lower than648mg/cm2. 
Severe osteoporosis is when there has been fragility fracture. 
In 1963, single-photon absorptiometry (SPA) was introduced. This device 
could quantitatively measure the BMD of the peripheral bones (Cameron and 
Sorenson 1963). The energy level used was sufficient for the BMD measurement of 
appendicular bones but not for that of central skeletal sites.15 Dual-photon 
absorptiometry (DPA) was then developed (WAHNER et al 1988). Both SPA and 
DPA used radionuclide sources that decayed and required regular replacement. With 
the slow scanning, there occurred undesirable incidents, such as the patients moving 
during the scan, rendering poor quality of the image and limiting reproducibility. In 
the mid-1980s, DXA was developed. Unlike the 2 previous devices, DXA used low-
energy x-ray beam with high photon flux that permitted faster scanning. 
Currently available methods for measuring bone mineral density in our 
country include: 
1. Dual energy X-ray absorptiomety ( DXA) 
2. Quantitative computed tomography (QCT) 
3. Single energy X-ray absorptiometry (SXA) 
In most centers the best method for BMD measurement is central DXA scan.  
 
Three major roles are: 
1. Diagnosis of osteoporosis 
2. Assessment of patient's risk of fracture 
3. Monitoring response of treatment 
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The advantages of using central DXA scan include: 
1. The hip BMD is the most reliable measurement for prediction of hip  
 fracture risk and the predictive value is similar both in men and women 
(Johnell et al 2005). 
2. The use of spine BMD for monitoring treatment. 
3. The consensus that in post menopausal women and older men the spine  
 and hip DXA scan should be interpreted using WHO t-score definition of 
osteoporosis. 
4. Short scan time, easy patient set up for scanning, low radiation dose ,  
 stable calibration, availability of reliable reference range and good 
measurement precision. 
 
DXA scanners evaluate bone mineral density by measuring the transmission 
of X-rays through the body at two different photon energies. The X-ray transmission 
through any physical object can be decomposed into the equivalent areal densities 
(g/cm2) of any two chosen reference material. The two materials for DXA scan are 
bone mineral and the soft tissue. Provided that the object under study composed 
solely of the two reference material, the computed areal densities will accurately 
reflect the densities. There are limitations of this method. The scan is a two 
dimensional (2D) projection image, the measurement of areal densities are affected 
by bone size and the true 3D volumetric density of the bone. This problem causes the 
difficulty with the interpretation of paediatric DXA. It may affect adults reading to 
certain extent as well causing difference between gender and ethnic group and also 
less obvious effect due different bone sizes in different individuals. 
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Central DXA scan involve examination of the hip and spine. The results 
are presented as T-score and Z-score (Figure 2.6). The T-score are calculated by 
taking the difference between patient's measured BMD and the mean BMD of 
young adults matched for gender and ethnic group and expressing the difference 
relative to the young adult population standard deviation. It is used to diagnose 
the severity of osteoporosis. 
 
𝑇 𝑠𝑐𝑜𝑟𝑒 = Measured BMD − Mean BMD of young adult Standard Deviation of young adult population 
 
The hip and spine DXA scan results in postmenopausal women and adults 
more than 50 years are interpreted using T-score according to the WHO definition of 
osteoporosis (Table 2.1). 
The Z-score is calculated by taking the difference between patients measured 
BMD and healthy subjects matched for age, gender and ethnic group. 
 
𝑍 𝑠𝑐𝑜𝑟𝑒 = Measured BMD − Age matched mean BMDStandard Deviation of age matched population 
 
The Z-score is used to identify patients who are at risk for fracture. The 
evaluation of fracture risk is determined by prospective studies of incident of 
fractures. When patients are divided into quartile on the basis of their BMD, an 
inverse relationship is found between fracture incidence and BMD. To describe this 
relationship, the data are fitted with a gradient- of-risk model in which the fracture 
probability increases exponentially with decreasing Z score with gradient. Results are 
usually expressed in terms of the relative risk (RR), which is defined as the increased 
risk of fracture for each unit decrease in Z score. 
